Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Orthopedics
Volume 2017, Article ID 1675654, 3 pages
https://doi.org/10.1155/2017/1675654
Case Report

A Case of an Insufficiency Fracture of the Medial Proximal Tibia Secondary to Osteomalacia Associated with Long-Term Saccharated Ferric Oxide Administration

1Department of Orthopaedic Surgery, Gujo Municipal Hospital, 1261 Shimatani, Hachiman, Gujo, Gifu, Japan
2Department of Orthopaedic Surgery, Sumi Memorial Hospital, 2-1 Shirotori, Gujo, Gifu, Japan

Correspondence should be addressed to Daichi Ishimaru; pj.oc.oohay@3002ihciaduramihsi

Received 7 April 2017; Accepted 4 June 2017; Published 4 July 2017

Academic Editor: Hitesh N. Modi

Copyright © 2017 Daichi Ishimaru and Hiroshi Sumi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Sato and M. Shiraki, “Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy,” Endocrine Journal, vol. 45, no. 4, pp. 431–439, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Okada, K. Imamura, M. Iida, T. Fuchigami, and T. Omae, “Hypophosphatemia induced by intravenous administration of saccharated iron oxide,” Klinische Wochenschrift, vol. 61, no. 2, pp. 99–102, 1983. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Sato, K. Nohtomi, H. Demura et al., “Saccharated ferric oxide (SFO)-Induced osteomalacia: in vitro inhibition by SFO of bone formation and 125-dihydroxy-vitamin D production in renal tubules,” Bone, vol. 21, no. 1, pp. 57–64, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Cuenca, J. A. García-Erce, A. A. Martínez, V. M. Solano, J. Molina, and M. Muñoz, “Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: Preliminary data,” Archives of Orthopaedic and Trauma Surgery, vol. 125, no. 5, pp. 342–347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Serrano-Trenas, P. F. Ugalde, L. M. Cabello, L. C. Chofles, P. S. Lázaro, and P. C. Benítez, “Role of perioperative intravenous iron therapy in elderly hip fracture patients: A single-center randomized controlled trial,” Transfusion, vol. 51, no. 1, pp. 97–104, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Shimizu, Y. Tada, M. Yamauchi et al., “Hypophosphatemia induced by intravenous administration of saccharated ferric oxide. Another form of FGF23-related hypophosphatemia,” Bone, vol. 45, no. 4, pp. 814–816, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Suzuki, H. Ohoike, Y. Matsuoka, and S. Irimajiri, “Iatrogenic osteomalacia caused by intravenous administration of saccharated ferric oxide,” American Journal of Hematology, vol. 43, no. 1, pp. 75-76, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Yamamoto, Y. Okada, H. Mori, S. Fukumoto, and Y. Tanaka, “Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide,” Internal Medicine, vol. 51, no. 17, pp. 2375–2378, 2012. View at Publisher · View at Google Scholar · View at Scopus